Japan Establishes Points for Drug Review Process
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) recently published an English translation of points to be considered during the evaluation process of a new drug. The original Japanese version was published in April 2008. The five main points the document emphasized were... Read More